Skip to Main Content

Paper Details

Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer.
Ann Oncol
236
2018
Author NameAffiliation
Rebecca NagyInc.
Anthony J IafrateMassachusetts General Hospital Cancer Center, Harvard Medical School
Aditya BardiaMassachusetts General Hospital Cancer Center, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2